St Jude on track for 2012 EU launch of Portico transcatheter heart valve
This article was originally published in Clinica
Executive Summary
St Jude Medical has implanted the first patient with its Portico transcatheter aortic heart valve in a European study designed to support CE mark approval. It means the company is on track to launch the valve in Europe by the end of 2012 on a limited basis; however, rival Edwards Lifesciences is likely to remain the leader in the transcatheter aortic valve implantation (TAVI) over the long term, according to Morgan Stanley analyst David Lewis.